Low rate of HIV-1 codon 215 revertants in antiretroviral-experienced patients

AIDS

Volumn 17, Issue 6, 2003, Pages 919-921

  Gallego, Oscar ^a   De Mendoza, Carmen ^a   Corral, Angélica ^a   Soriano, Vincent ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; STAVUDINE; ZIDOVUDINE;

ARTICLE; CODON; GENE MUTATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; PRIMARY INFECTION; PRIORITY JOURNAL; VIRUS RESISTANCE;

ANTI-HIV AGENTS; CODON; DRUG RESISTANCE, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; MUTATION; TREATMENT FAILURE;

EID: 0037964270     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200304110-00020     Document Type: Article

References (8)

1. Boucher C, O'Sullivan E, Mulder J, Ramautarsing C, Kellam P, Darby G, et al. Ordered appearance of zidovudine resistance mutations during treatment of 18 HIV-positive subjects. J Infect Dis 1992, 165:105-110.
2. Larder B, Kemp S. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine. Science 1989, 246:1155-1158.
3. De Ronde A, Van Dooren M, Van der Hoek L, Bouwhuis D, de Rooij E, van Gemen B, et al. Establishment of new transmissible and drug-sensitive HIV type 1 wild type due to transmission of nucleoside analogue-resistant virus. J Virol 2001, 75:595-602.
4. García-Lerma J, Nidtha S, Blumoff K, Weinstock H, Heneine W. Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons. Proc Natl Acad Sci U S A 2001, 98:13907-13912.
5. Yerly S, Rakik A, Kinloch de Loes S, Hirschel B, Descamps D, Brun-Vezinet F, et al. Switch to unusual amino acids at codon 215 of the HIV type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants. J Virol 1998, 72:3250-3253.
6. García-Lerma J, MacInmes H, Nidtha S, Bennett D, Weinstock H, Heneine W. In vitro selection of the T215Y mutation by stavudine (d4T) in viruses carrying 215D/C from drug-naive persons. In: 9th Conference on Retroviruses and Opportunistic Infections. Seattle, February 2002 [Abstract 571-T].
7. Eron J, Vernaza P, Johnston D, Seillier-Moiseiwitsch F, Alcom T, Fiscus S, et al. Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: i: implications for transmission. AIDS 1998, 12:F181-F189.
8. Jeeninga R, Keulen W, Boucher C, Sanders R, Be Berkout B. Evolution of AZT resistance in HIV-1: the 41-70 intermediate that is not observed in vivo has a replication defect. Virology 2001, 283:294-305.